- Home
- AGEN vs WRAP Comparison
AGEN vs WRAP Comparison
Compare AGEN & WRAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- WRAP
- Stock Information
- Founded
- AGEN 1994
- WRAP 2016
- Country
- AGEN United States
- WRAP United States
- Employees
- AGEN N/A
- WRAP N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- WRAP Ordnance And Accessories
- Sector
- AGEN Health Care
- WRAP Industrials
- Exchange
- AGEN Nasdaq
- WRAP Nasdaq
- Market Cap
- AGEN 87.7M
- WRAP 73.3M
- IPO Year
- AGEN 2000
- WRAP N/A
- Fundamental
- Price
- AGEN $4.28
- WRAP $1.37
- Analyst Decision
- AGEN Buy
- WRAP
- Analyst Count
- AGEN 2
- WRAP 0
- Target Price
- AGEN $14.50
- WRAP N/A
- AVG Volume (30 Days)
- AGEN 497.3K
- WRAP 191.9K
- Earning Date
- AGEN 08-11-2025
- WRAP 08-14-2025
- Dividend Yield
- AGEN N/A
- WRAP N/A
- EPS Growth
- AGEN N/A
- WRAP N/A
- EPS
- AGEN N/A
- WRAP N/A
- Revenue
- AGEN $101,706,000.00
- WRAP $3,236,000.00
- Revenue This Year
- AGEN $26.25
- WRAP N/A
- Revenue Next Year
- AGEN N/A
- WRAP N/A
- P/E Ratio
- AGEN N/A
- WRAP N/A
- Revenue Growth
- AGEN N/A
- WRAP N/A
- 52 Week Low
- AGEN $1.38
- WRAP $1.20
- 52 Week High
- AGEN $7.34
- WRAP $2.58
- Technical
- Relative Strength Index (RSI)
- AGEN 38.46
- WRAP 47.23
- Support Level
- AGEN $4.31
- WRAP $1.26
- Resistance Level
- AGEN $4.70
- WRAP $1.44
- Average True Range (ATR)
- AGEN 0.26
- WRAP 0.09
- MACD
- AGEN -0.01
- WRAP -0.00
- Stochastic Oscillator
- AGEN 17.86
- WRAP 25.86
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.